Insabato, Luigi, Quarto, Maria, Riccio, Patrizia and Condorelli, Gerolama (2009) Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors. [Pubblicazione in rivista scientifica]
Full text not available from this repository.Item Type: | Pubblicazione in rivista scientifica |
---|---|
Resource language: | English |
Title: | Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors. |
Creators: | Creators Email Insabato, Luigi UNSPECIFIED Quarto, Maria UNSPECIFIED Riccio, Patrizia UNSPECIFIED Condorelli, Gerolama UNSPECIFIED |
Autore/i: | Insabato L., Amelio I., Quarto M., Zannetti A., Tolino F., de Mauro G., Cerchia L., Riccio P., Baumhoer D., Condorelli G., Terracciano L., de Franciscis V. |
Date: | 2009 |
Number of Pages: | 7 |
Department: | Scienze fisiche |
Original publication URL: | http://content.karger.com/produktedb/produkte.asp?... |
Journal or Publication Title: | ONCOLOGY |
Date: | 2009 |
Volume: | 77 |
Number: | 6 |
Page Range: | pp. 378-384 |
Number of Pages: | 7 |
Date Deposited: | 21 Oct 2010 06:57 |
Last Modified: | 30 Apr 2014 19:43 |
URI: | http://www.fedoa.unina.it/id/eprint/7498 |
Collection description
OBJECTIVES: Protein tyrosine phosphatases are key regulators of intracellular signaling that contribute to determining cancer cell growth, which thus makes them attractive targets for therapeutic and diagnostic agents. SHP-1 phosphotyrosine phosphatase is rarely expressed in epithelial tumor cells, but expression has been found in several breast cancer cell lines and tumors. To determine the potential significance of SHP-1 as a prognostic marker in the clinical setting, we examined SHP-1 protein expression in breast tumors. METHODS: We analyzed SHP-1 expression by immunohistochemistry in a breast tissue microarray composed of 2,081 cores, either alone or in combination with known prognostic markers. RESULTS: Our data showed that SHP-1 expression was confined to a well-defined subset of high-grade tumors characterized by unique biological parameters. SHP-1 expression correlated directly with expression of the tyrosine kinase receptor HER-2 and inversely with expression of the estrogen receptor, while it was weakly associated with Bcl-2 expression. CONCLUSIONS: Levels of SHP-1 were correlated with conventional pathologic parameters of tumor aggressiveness and were associated with reduced patient survival, suggesting that elevated expression of SHP-1 is a common molecular abnormality in a defined subset of breast tumors and might be used in routine diagnosis to identify patients with high-risk tumors.
Downloads
Downloads per month over past year
Actions (login required)
![]() |
View Item |